The U.S. Food and Drug Administration (FDA) has ordered Bayer, the company that manufactures Essure, to conduct a new postmarket surveillance study for the permanent birth control device. The purpose of the study is “to provide important information about the risks of the device in a real-world environment.” Essure is a permanent birth control method...
FDA Orders Bayer to Conduct Postmarket Surveillance Study of Risks of Essure
